Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 410

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation

Open access
Sohns, Christian, Fox, Henrik, Marrouche, Nassir F., Crijns, Harry J.G.M., Costard-Jaeckle, Angelika, Bergau, Leonard, Hindricks, Gerhard, Dagres, Nikolaos, Sossalla, Samuel, Schramm, Rene, Fink, Thomas, El Hamriti, Mustapha, Moersdorf, Maximilian, Sciacca, Vanessa, Konietschke, Frank, Rudolph, Volker, Gummert, Jan, Tijssen, Jan G.P., Sommer, Philipp · 2023 · New England Journal of Medicine

Abstract

BACKGROUND: The role of catheter ablation in patients with symptomatic atrial fibrillation and end-stage heart failure is unknown. METHODS: We conducted a single-center, open-label trial in Germany that involved patients with symptomatic atrial fibrillation and end-stage heart failure who were referred for heart transplantation evaluation. Patients were assigned to receive catheter ablation and guideline-directed medical therapy or medical therapy alone. The primary end point was a composite of death from any cause, implantation of a left ventricular assist device, or urgent heart transplantation. RESULTS: A total of 97 patients were assigned to the ablation group and 97 to the medical-therapy group. The trial was stopped for efficacy by the data and safety monitoring board 1 year after randomization was completed. Catheter ablation was performed in 81 of 97 patients (84%) in the ablation group and in 16 of 97 patients (16%) in the medical-therapy group. After a median follow-up of 18.0 months (interquartile range, 14.6 to 22.6), a primary end-point event had occurred in 8 patients (8%) in the ablation group and in 29 patients (30%) in the medical-therapy group (hazard ratio, 0.24; 95% confidence interval [CI], 0.11 to 0.52; P<0.001). Death from any cause occurred in 6 patients (6%) in the ablation group and in 19 patients (20%) in the medical-therapy group (hazard ratio, 0.29; 95% CI, 0.12 to 0.72). Procedure-related complications occurred in 3 patients in the ablation group and in 1 patient in the medical-therapy group. CONCLUSIONS: Among patients with atrial fibrillation and end-stage heart failure, the combination of catheter ablation and guideline-directed medical therapy was associated with a lower likelihood of a composite of death from any cause, implantation of a left ventricular assist device, or urgent heart transplantation than medical therapy alone. (Funded by Else Kröner-Fresenius-Stiftung; CASTLE-HTx ClinicalTrials.gov number, NCT04649801.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2306037

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 410

Metadata

Authors
Sohns, C., Fox, H., Marrouche, N. F., Crijns, H. J. G. M., Costard-Jaeckle, A., Bergau, L., Hindricks, G., Dagres, N., Sossalla, S., Schramm, R., Fink, T., El Hamriti, M., Moersdorf, M., Sciacca, V., Konietschke, F., Rudolph, V., Gummert, J., Tijssen, J. G. P., & Sommer, P.
Venue
New England Journal of Medicine
Published
2023-10-12
Volume
389
Issue
15
Pages
1380-1389
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4386207084
Cited by
410
References
22
FWCI
72.12
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation. https://app.cochat.ai/papers/10.1056/nejmoa2306037
The paper
Sohns, C., Fox, H., Marrouche, N. F., Crijns, H. J. G. M., Costard-Jaeckle, A., Bergau, L., Hindricks, G., Dagres, N., Sossalla, S., Schramm, R., Fink, T., El Hamriti, M., Moersdorf, M., Sciacca, V., Konietschke, F., Rudolph, V., Gummert, J., Tijssen, J. G. P., & Sommer, P. (2023). Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2306037

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.